Literature DB >> 28284782

First case of allergy to nivolumab.

Mercedes Sáenz de Santa María García1, Blanca Noguerado-Mellado2, Patricia Rojas-Pérez-Ezquerra2, Alicia Prieto-García2, Borja Bartolomé-Zavala3, Pilar Tornero2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28284782     DOI： 10.1016/j.jaip.2017.01.015

Source DB:  PubMed          Journal:  J Allergy Clin Immunol Pract


× No keyword cloud information.
  5 in total

1.  The Role of Immunotherapy in Hepatocellular Carcinoma: A Systematic Review and Pooled Analysis of 2,402 Patients.

Authors:  Ioannis A Ziogas; Alexandros P Evangeliou; Lipika Goyal; Georgios Tsoulfas; Dimitrios Giannis; Muhammad H Hayat; Konstantinos S Mylonas; Samer Tohme; David A Geller; Nahel Elias
Journal:  Oncologist       Date:  2021-01-02

2.  Camrelizumab-induced anaphylactic shock in an esophageal squamous cell carcinoma patient: A case report and review of literature.

Authors:  Kai Liu; Jian-Feng Bao; Tao Wang; Hao Yang; Bao-Ping Xu
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

3.  Severe infusion reaction due to nivolumab: A case report.

Authors:  Seema Kumari; James Yun; James R Soares; Pei N Ding
Journal:  Cancer Rep (Hoboken)       Date:  2020-05-04

Review 4.  Coronary Toxicities of Anti-PD-1 and Anti-PD-L1 Immunotherapies: a Case Report and Review of the Literature and International Registries.

Authors:  Marion Ferreira; Eric Pichon; Delphine Carmier; Emilie Bouquet; Cécile Pageot; Theodora Bejan-Angoulvant; Marion Campana; Emmanuelle Vermes; Sylvain Marchand-Adam
Journal:  Target Oncol       Date:  2018-08       Impact factor: 4.493

5. 

Authors:  Askin Gülsen; Bettina Wedi; Uta Jappe
Journal:  Allergo J       Date:  2020-06-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.